Restless legs syndrome: A new comorbidity in idiopathic pulmonary fibrosis

Respir Med. 2020 Aug-Sep:170:105982. doi: 10.1016/j.rmed.2020.105982. Epub 2020 Apr 22.

Abstract

Objective: Sleep disorders have a high prevalence among patients with idiopathic pulmonary fibrosis (IPF). The prevalence of restless legs syndrome (RLS) is not known in these patients, neither is its clinical impact as a comorbidity. We investigated the association of RLS with IPF and characterized the clinical features of RLS in a cohort of IPF patients.

Methods: Fifty patients with diagnosis of IPF were prospectively enrolled. RLS was diagnosed using the validated 5-item RLS criteria. Sleep quality was evaluated using the Pittsburgh Sleep Quality Index. The prevalence of RLS in the IPF group was compared to that observed in a group of 293 patients referred for suspect of sleep disorders. The relationships between RLS and clinical parameters were determined using multivariate logistic regression.

Results: Prevalence of RLS in the IPF group was significantly higher than in the control population of patients referred for sleep disorders (IPF: 24%, controls 10%: χ2 6.49, p = 0.011). Higher PSQI score confirmed to be associated with RLS after adjusting for demographics and clinical parameters of disease severity (OR = 1.38, 95%CI 1.08-1.76; p = 0.01).

Conclusions: RLS is highly prevalent in IPF and significantly worsen sleep quality in these patients. The benefit/risk ratio of a specific therapeutic intervention for RLS in IPF should be assessed in further prospective research.

Keywords: Idiopathic pulmonary fibrosis; Interstitial lung disease; Restless legs syndrome; Sleep quality; Sleep-related movements disorders.

MeSH terms

  • Aged
  • Comorbidity
  • Female
  • Humans
  • Idiopathic Pulmonary Fibrosis / epidemiology*
  • Male
  • Middle Aged
  • Prevalence
  • Prospective Studies
  • Quality of Life
  • Restless Legs Syndrome / epidemiology*
  • Severity of Illness Index
  • Sleep